Metraipolis › archive › dc_caae89df11bd
Risk factors for adverse events associated with trimethoprim-sulfamethoxazole treatment for Pneumocystis pneumonia in non-human immunodeficiency… — Europe PMC PMID:41559609
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41559609
- DOI
- 10.1186/s12879-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T16:44:51.587Z
- SHA-256 of the archived text
b68e11a354a682a0b884ccc47d1df2a90a96009c6fff1e5c60c6646a4702fa77- Stable URL of this page
https://metraipolis.com/documento/dc_caae89df11bd
How to cite
Risk factors for adverse events associated with trimethoprim-sulfamethoxazole treatment for Pneumocystis pneumonia in non-human immunodeficiency… — Europe PMC PMID:41559609 — Europe PMC (en), https://europepmc.org/article/MED/41559609 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_caae89df11bd (Metraipolis archive dc_caae89df11bd, sha256 b68e11a354a682a0b884ccc47d1df2a90a96009c6fff1e5c60c6646a4702fa77)
BibTeX
@misc{dccaae89df11bd,
title = {Risk factors for adverse events associated with trimethoprim-sulfamethoxazole treatment for Pneumocystis pneumonia in non-human immunodeficiency… — Europe PMC PMID:41559609},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41559609},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_caae89df11bd; sha256 b68e11a354a682a0b884ccc47d1df2a90a96009c6fff1e5c60c6646a4702fa77},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41559609. Agents can read the archived copy with the MCP tool read_document.